Disclaimer
CompoundIQ publishes research summaries for informational and educational purposes only. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. Always consult a licensed healthcare provider. Many compounds listed are research chemicals not approved for human use.
Noopept
Also known as: GVS-111, Omberacetam
Noopept is a synthetic dipeptide nootropic developed in Russia, often grouped with racetams but structurally distinct. It is estimated to be 1000 times more potent than piracetam by dose and has demonstrated neuroprotective and neurorestorative properties through upregulation of BDNF and NGF in animal models.
Risk Level
Low RiskDifficulty
Intermediate| CAS Number | 157115-85-0 |
| Molecular Formula | C17H22N2O4 |
| Class | Other |
| Category | Nootropics |
Mechanism of Action
Noopept is metabolized to cycloprolylglycine, which modulates AMPA and NMDA receptor activity. It increases expression of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) in the hippocampus and cerebral cortex, promoting neuroplasticity and neuronal survival. It also has antioxidant and anti-inflammatory effects, and enhances alpha and beta brain wave activity.
Dosing Research
Typical dose: 10-30 mg/day, taken sublingually or orally in 1-3 divided doses. Most common: 10 mg two to three times daily. Sublingual administration preferred for better bioavailability. Effects felt within 15-20 minutes sublingually. Half-life approximately 30-60 minutes, but neurotrophic effects are cumulative. Cycle 56 days on, 4 days off (per Russian prescribing information).
Side Effects & Risks
Generally well-tolerated at standard doses. Headache, irritability, restlessness at higher doses. Some users report brain fog or emotional flatness with prolonged use. Insomnia if taken in the evening. Very low toxicity in animal studies. No known dependency or withdrawal issues.
Research Studies
Related compounds
Finasteride
OtherFinasteride is a selective type II 5-alpha reductase inhibitor approved for male pattern hair loss (1 mg, Propecia) and benign prostatic hyperplasia (5 mg, Proscar). It reduces scalp DHT levels by approximately 60-70% and is one of only two FDA-approved oral medications for androgenetic alopecia. It has decades of clinical data supporting its efficacy.
Tamoxifen
OtherTamoxifen is a selective estrogen receptor modulator (SERM) that has been the gold standard for breast cancer treatment and prevention since the 1970s. It is one of the most widely used compounds in post-cycle therapy (PCT) for restoring endogenous testosterone production after anabolic steroid use.
Clomiphene Citrate
OtherClomiphene citrate is a SERM originally developed for female ovulation induction and widely adopted in PCT protocols and off-label male hypogonadism treatment. It is a racemic mixture of two geometric isomers, enclomiphene (trans) and zuclomiphene (cis), with differing estrogenic properties.
Anastrozole
OtherAnastrozole is a potent, selective non-steroidal aromatase inhibitor that reduces estradiol levels by approximately 80-85%. It is widely used in breast cancer treatment and is the most commonly employed AI during anabolic steroid cycles to manage estrogen-related side effects.
Disclaimer
CompoundIQ publishes research summaries for informational and educational purposes only. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. Always consult a licensed healthcare provider. Many compounds listed are research chemicals not approved for human use.